Your browser doesn't support javascript.
loading
The lysosomal trafficking regulator "LYST": an 80-year traffic jam.
Turner, Mackenzie E; Che, Jingru; Mirhaidari, Gabriel J M; Kennedy, Catherine C; Blum, Kevin M; Rajesh, Sahana; Zbinden, Jacob C; Breuer, Christopher K; Best, Cameron A; Barker, Jenny C.
Afiliación
  • Turner ME; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
  • Che J; Molecular and Cellular Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, United States.
  • Mirhaidari GJM; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
  • Kennedy CC; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
  • Blum KM; The Ohio State University College of Medicine, Columbus, OH, United States.
  • Rajesh S; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
  • Zbinden JC; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
  • Breuer CK; The Ohio State University College of Medicine, Columbus, OH, United States.
  • Best CA; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
  • Barker JC; Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
Front Immunol ; 15: 1404846, 2024.
Article en En | MEDLINE | ID: mdl-38774881
ABSTRACT
Lysosomes and lysosome related organelles (LROs) are dynamic organelles at the intersection of various pathways involved in maintaining cellular hemostasis and regulating cellular functions. Vesicle trafficking of lysosomes and LROs are critical to maintain their functions. The lysosomal trafficking regulator (LYST) is an elusive protein important for the regulation of membrane dynamics and intracellular trafficking of lysosomes and LROs. Mutations to the LYST gene result in Chédiak-Higashi syndrome, an autosomal recessive immunodeficiency characterized by defective granule exocytosis, cytotoxicity, etc. Despite eight decades passing since its initial discovery, a comprehensive understanding of LYST's function in cellular biology remains unresolved. Accumulating evidence suggests that dysregulation of LYST function also manifests in other disease states. Here, we review the available literature to consolidate available scientific endeavors in relation to LYST and discuss its relevance for immunomodulatory therapies, regenerative medicine and cancer applications.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Transporte Vesicular / Lisosomas Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas de Transporte Vesicular / Lisosomas Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos